Top

Journal of Experimental & Clinical Cancer Research

Published in:

Open Access 01-12-2012 | Retraction Note

Retraction Note: screening and identification of a renal carcinoma specific peptide from a phage display peptide library

Authors: Xiangan Tu, Jintao Zhuang, Wenwei Wang, Liang Zhao, Liangyun Zhao, Jiquan Zhao, Chunhua Deng, Shaopeng Qiu, Yuanyuan Zhang

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2012

Excerpt

The authors would like to retract the article "Screening and Identification of a Renal Carcinoma Specific Peptide from a Phage Display Peptide Library" [1]. After the article was published it was revealed that the data in figure three, reported to show the Immunohistochemical staining of renal carcinoma, actually shows the results from an unrelated experiment on lung tissue due to incorrect labeling. The authors apologize to the readers, reviewers, and editors for publishing this erroneous data. …

Tu X, Zhuang J, Wang W, Zhao L, Zhao L, Zhao J, Deng C, Qiu S, Zhang Y: Screening and Identification of a Renal Carcinoma Specific Peptide from a Phage Display Peptide Library. J Exp Clin Cancer Res. 2011, 30: 105-10.1186/1756-9966-30-105.PubMedCentralCrossRefPubMed

Title: Retraction Note: screening and identification of a renal carcinoma specific peptide from a phage display peptide library
Authors: Xiangan Tu
Jintao Zhuang
Wenwei Wang
Liang Zhao
Liangyun Zhao
Jiquan Zhao
Chunhua Deng
Shaopeng Qiu
Yuanyuan Zhang
Publication date: 01-12-2012
Publisher: BioMed Central
Published in: Journal of Experimental & Clinical Cancer Research / Issue 1/2012
Electronic ISSN: 1756-9966
DOI: https://doi.org/10.1186/1756-9966-31-21

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2012

Evaluation of antigen specific recognition and cell mediated cytotoxicity by a modified lysispot assay in a rat colon carcinoma model

Differential Expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues

Down-regulation of the PI3K/Akt signaling pathway and induction of apoptosis in CA46 Burkitt lymphoma cells by baicalin

Downregulation of gastrokine-1 in gastric cancer tissues and restoration of its expression induced gastric cancer cells to apoptosis

Polymorphisms in the p63 and p73 genes are associated with ovarian cancer risk and clinicopathological variables

Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?

Keynote webinar | Spotlight on antibody–drug conjugates in cancer